Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
暂无分享,去创建一个
T. Chatila | M. Gursel | S. Barış | L. Charbonnier | E. Karakoc‐Aydiner | S. B. Eltan | A. Ozen | G. Ozturk | Nurhan Kasap | A. Akçay | Başak Kayaoğlu | Busranur Geckin | Naz Surucu Yilmaz | Busranur Geckin